U.S. Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Whole Exome Sequencing, Targeted Sequencing & Resequencing), By Product (Platforms, Consumables), By Application, By Workflow, By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                        1.2.1. Technology
                        1.2.2. Product
                        1.2.3. Application
                        1.2.4. Workflow
                        1.2.5. End-use
                    1.3. Information analysis
                    1.4. Market formulation & data visualization
                    1.5. Data validation & publishing
                    1.6. Information Procurement
                        1.6.1. Primary Research
                    1.7. Information or Data Analysis
                    1.8. Market Formulation & Validation
                    1.9. Market Model
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Decreasing costs for genetic sequencing
                            3.2.1.2. Development of companion diagnostics and personalized medicine
                            3.2.1.3. Rise in competition among prominent market entities
                            3.2.1.4. Rising clinical opportunity for NGS technology
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Lack of computational efficiency for data management
                            3.2.2.2. Challenges associated with NGS implementation
                    3.3. Industry Analysis Tools
                        3.3.1. Porter's Five Forces Analysis
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. NGS Market: Technology Business Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. NGS Market Technology Movement Analysis
                    4.3. U.S. NGS Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
                    4.4. Targeted Sequencing & Resequencing
                        4.4.1. Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
                            4.4.1.1. DNA-based targeted sequencing & resequencing
                                4.4.1.1.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
                            4.4.1.2. RNA-based targeted sequencing & resequencing
                                4.4.1.2.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
                    4.5. Whole Genome Sequencing
                        4.5.1. Whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
                    4.6. Whole Exome Sequencing
                        4.6.1. Whole exome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. U.S. NGS Market: Product Business Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. NGS Market Product Movement Analysis
                    5.3. U.S. NGS Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    5.4. Platforms
                        5.4.1. Platforms market estimates and forecast, 2018 - 2030 (USD Million)
                            5.4.1.1. Sequencing
                                5.4.1.1.1. Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
                            5.4.1.2. Data Analysis
                                5.4.1.2.1. Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million
                    5.5. Consumables
                        5.5.1. Consumables market estimates and forecast, 2018 - 2030 (USD million)
                        5.5.2. Sample Preparation
                            5.5.2.1. Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
                        5.5.3. Target Enrichment
                            5.5.3.1. Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
                        5.5.4. Others
                            5.5.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. U.S. NGS Market: Application Business Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. NGS Market Application Movement Analysis
                    6.3. U.S. NGS Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                    6.4. Oncology
                        6.4.1. Oncology market estimates and forecast, 2018 - 2030 (USD Million)
                        6.4.2. Diagnostics & Screening
                            6.4.2.1. Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
                            6.4.2.2. Oncology screening
                                6.4.2.2.1. Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
                                6.4.2.2.2. Sporadic Cancer
                                    6.4.2.2.2.1. Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
                                6.4.2.2.3. Inherited Cancer
                                    6.4.2.2.3.1. Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
                            6.4.2.3. Companion diagnostics
                                6.4.2.3.1. Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
                            6.4.2.4. Other diagnostics
                                6.4.2.4.1. Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
                        6.4.3. Research Studies
                            6.4.3.1. Research studies market estimates and forecast, 2018 - 2030 (USD Million)
                    6.5. Clinical Investigation
                        6.5.1. Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
                        6.5.2. Infectious Diseases
                            6.5.2.1. Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
                        6.5.3. Idiopathic Diseases
                            6.5.3.1. Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
                        6.5.4. Inherited Diseases
                            6.5.4.1. Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
                        6.5.5. Non-Communicable/Other Diseases
                            6.5.5.1. Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
                    6.6. Reproductive Health
                        6.6.1. Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
                        6.6.2. NIPT
                            6.6.2.1. NIPT market estimates and forecast, 2018 - 2030 (USD Million)
                            6.6.2.2. Aneuploidy
                                6.6.2.2.1. Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
                            6.6.2.3. Microdeletions
                                6.6.2.3.1. Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
                        6.6.3. PGT
                            6.6.3.1. PGT market estimates and forecast, 2018 - 2030 (USD Million)
                        6.6.4. Newborn Genetic Screening
                            6.6.4.1. Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
                        6.6.5. Single Gene Analysis
                            6.6.5.1. Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
                    6.7. HLA Typing/Immune System Monitoring
                        6.7.1. HLA typing/immune system monitoring market estimates and forecast, 2018 - 2030 (USD Million)
                    6.8. Metagenomics, Epidemiology & Drug Development
                        6.8.1. Metagenomics, epidemiology & drug development market estimates and forecast, 2018 - 2030 (USD Million)
                    6.9. Agrigenomics & Forensics
                        6.9.1. Agrigenomics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
                    6.10. Consumer Genomics
                        6.10.1. Consumer genomics market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. U.S. NGS Market: Workflow Business Analysis
                    7.1. Segment Dashboard
                            7.2. U.S. NGS Market Workflow Movement Analysis
                            7.3. U.S. NGS Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
                    7.4. Pre-sequencing
                        7.4.1. Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
                        7.4.2. Library Preparation
                            7.4.2.1. Library preparation market estimates and forecast, 2018 - 2030 (USD Million)
                            7.4.2.2. NGS Library Preparation Kits
                                7.4.2.2.1. NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
                            7.4.2.3. Semi-automated Library Preparation
                                7.4.2.3.1. Semi-automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
                            7.4.2.4. Automated Library Preparation
                                7.4.2.4.1. Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
                        7.4.3. Others
                            7.4.3.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
                    7.5. Sequencing
                        7.5.1. Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
                    7.6. Data Analysis
                        7.6.1. Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
                        7.6.2. NGS Primary Data Analysis
                            7.6.2.1. NGS primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
                        7.6.3. NGS Secondary Data Analysis
                            7.6.3.1. NGS secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
                        7.6.4. NGS Tertiary Data Analysis
                            7.6.4.1. NGS tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. U.S. NGS Market: End-use Business Analysis
                    8.1. Segment Dashboard
                    8.2. U.S. NGS Market End-use Movement Analysis
                    8.3. U.S. NGS Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
                    8.4. Academic Research
                        8.4.1. Academic research market estimates and forecast, 2018 - 2030 (USD Million)
                    8.5. Clinical Research
                        8.5.1. Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
                    8.6. Hospitals & Clinics
                        8.6.1. Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
                    8.7. Pharmaceutical & Biotech Entities
                        8.7.1. Pharmaceutical & biotech entities market estimates and forecast, 2018 - 2030 (USD Million)
                    8.8. Other Users
                        8.8.1. Other users market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Participant Categorization
                    9.2. Strategy Mapping
                    9.3. Company Market Position Analysis, 2023
                    9.4. Participant’s Overview
                        9.4.1. Illumina
                            9.4.1.1. Overview
                            9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.1.3. Product Benchmarking
                            9.4.1.4. Strategic Initiatives
                        9.4.2. QIAGEN
                            9.4.2.1. Overview
                            9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.2.3. Product Benchmarking
                            9.4.2.4. Strategic Initiatives
                        9.4.3. Thermo Fisher Scientific, Inc.
                            9.4.3.1. Overview
                            9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.3.3. Product Benchmarking
                            9.4.3.4. Strategic Initiatives
                        9.4.4. Bio-Rad Laboratories, Inc.
                            9.4.4.1. Overview
                            9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.4.3. Product Benchmarking
                            9.4.4.4. Strategic Initiatives
                        9.4.5. Oxford Nanopore Technologies
                            9.4.5.1. Overview
                            9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.5.3. Product Benchmarking
                            9.4.5.4. Strategic Initiatives
                        9.4.6. Pacific Biosciences
                            9.4.6.1. Overview
                            9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.6.3. Product Benchmarking
                            9.4.6.4. Strategic Initiatives
                        9.4.7. Agilent Technologies, Inc
                            9.4.7.1. Overview
                            9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.7.3. Product Benchmarking
                            9.4.7.4. Strategic Initiatives
                        9.4.8. BGI
                            9.4.8.1. Overview
                            9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.8.3. Product Benchmarking
                            9.4.8.4. Strategic Initiatives
                        9.4.9. F. Hoffmann-La Roche AG
                            9.4.9.1. Overview
                            9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.9.3. Product Benchmarking
                            9.4.9.4. Strategic Initiatives
                        9.4.10. Eurofins Scientific
                            9.4.10.1. Overview
                            9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.4.10.3. Product Benchmarking
                            9.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. NGS market, by technology, 2018 - 2030 (USD Million)
Table 4 U.S. NGS market, by product, 2018 - 2030 (USD Million)
Table 5 U.S. NGS market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. NGS market, by workflow, 2018 - 2030 (USD Million)
Table 7 U.S. NGS market, by end-use, 2018 - 2030 (USD Million)
Table 8 Key companies undergoing expansions
Table 9 Key companies undergoing acquisitions
Table 10 Key companies undergoing collaborations
Table 11 Key companies launching new products
Table 12 Key companies undertaking other strategies

List of Figures

Fig. 1 U.S. NGS market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 U.S. NGS market driver analysis
Fig. 14 U.S. NGS market restraint analysis
Fig. 15 U.S. NGS market: Porter's analysis
Fig. 16 U.S. NGS market: PESTEL analysis
Fig. 17 U.S. NGS market: Technology movement analysis
Fig. 18 U.S. NGS market: Technology outlook and key takeaways
Fig. 19 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 DNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 RNA-based targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Whole genome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Whole exome sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 U.S. NGS market: Product outlook key takeaways
Fig. 25 U.S. NGS market: Product movement analysis
Fig. 26 Platforms market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Sequencing platforms market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Data analysis platforms market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Sample preparation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Target enrichment market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 U.S. NGS Market: Application Movement Analysis
Fig. 34 U.S. NGS market: Application outlook and key takeaways
Fig. 35 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Diagnostics & screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Oncology screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Sporadic cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Inherited cancer screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Companion diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Other diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Research studies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Clinical investigation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Idiopathic diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Inherited diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Non-communicable/other diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Aneuploidy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Microdeletions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 PGT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Single gene analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 HLA typing/immune system monitoring market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Metagenomics, epidemiology & drug development market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Agrigenomics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Consumer genomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 U.S. NGS market: Workflow movement analysis
Fig. 60 U.S. NGS market: Workflow outlook and key takeaways
Fig. 61 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Library preparation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 NGS library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Semiautomated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Automated library preparation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 NGS data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 NGS primary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 NGS secondary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 NGS tertiary data analysis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 U.S. NGS market End-use outlook key takeaways
Fig. 73 U.S. NGS market: End-use movement analysis
Fig. 74 Academic research market estimates and forecast, 2018 - 2030 (USD Million))
Fig. 75 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Pharmaceutical & biotech entities market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Other users market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Market participant categorization
Fig. 80 Company market positioning
Fig. 81 Strategy framework